Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
BMC Cancer|May 3, 2026
Co-targeting cystathionine gamma-lyase and mTOR: a promising therapeutic strategy in clear cell ovarian cancerLongyijie Wei, Amal M El-Naggar, Yuqin Li, et al.Cell Death & Disease|January 10, 2019
HACE1 is a potential tumor suppressor in osteosarcomaAmal M El-Naggar, Paul W Clarkson, Gian Luca Negri, et al.EMBO Reports|October 17, 2023
The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexesBusra Turgu, Amal El-Naggar, Melanie Kogler, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 1, 2020
Development of Helicobacter pylori Whole-Proteome Arrays and Identification of Serologic Biomarkers for Noncardia Gastric Cancer in the MCC-Spain StudyRima Jeske, Dennis Reininger, Busra Turgu, et al.Oncogene|February 19, 2021
HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent mannerBusra Turgu, Fan Zhang, Amal El-Naggar, et al.Science Advances|August 23, 2023
A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastomaHai-Feng Zhang, Alberto Delaidelli, Sumreen Javed, et al.The Journal of Pathology|May 15, 2025
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progressionAmal M El-Naggar, Yuqin Li, Busra Turgu, et al.Pageof 1